DE69133010D1 - Zur steigerung der antitumorimmunität wirksames proteoglykan (g009) - Google Patents

Zur steigerung der antitumorimmunität wirksames proteoglykan (g009)

Info

Publication number
DE69133010D1
DE69133010D1 DE69133010T DE69133010T DE69133010D1 DE 69133010 D1 DE69133010 D1 DE 69133010D1 DE 69133010 T DE69133010 T DE 69133010T DE 69133010 T DE69133010 T DE 69133010T DE 69133010 D1 DE69133010 D1 DE 69133010D1
Authority
DE
Germany
Prior art keywords
glucose
alpha
protoglycan
increase
components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69133010T
Other languages
English (en)
Other versions
DE69133010T2 (de
Inventor
Haeng Lee
Hoon Chung
Woo Lee
Hee Chung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Il Yang Pharmaceutical Co Ltd
Original Assignee
Il Yang Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Il Yang Pharmaceutical Co Ltd filed Critical Il Yang Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69133010D1 publication Critical patent/DE69133010D1/de
Publication of DE69133010T2 publication Critical patent/DE69133010T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/375—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from Basidiomycetes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Lubricants (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE69133010T 1990-12-04 1991-12-04 Zur steigerung der antitumorimmunität wirksames proteoglykan (g009) Expired - Fee Related DE69133010T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1019900019876A KR920010763B1 (ko) 1990-12-04 1990-12-04 항종양 면역증강효과가 있는 단백다당체(g 009)
PCT/KR1991/000031 WO1992010202A1 (fr) 1990-12-04 1991-12-04 Proteoglycane(g 009) servant efficacement a ameliorer l'immunite antitumorale

Publications (2)

Publication Number Publication Date
DE69133010D1 true DE69133010D1 (de) 2002-06-20
DE69133010T2 DE69133010T2 (de) 2002-12-05

Family

ID=19307027

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69133010T Expired - Fee Related DE69133010T2 (de) 1990-12-04 1991-12-04 Zur steigerung der antitumorimmunität wirksames proteoglykan (g009)

Country Status (9)

Country Link
US (1) US5585467A (de)
EP (1) EP0610499B1 (de)
JP (1) JP2583385B2 (de)
KR (1) KR920010763B1 (de)
AT (1) ATE217530T1 (de)
AU (2) AU8952191A (de)
CA (1) CA2097820C (de)
DE (1) DE69133010T2 (de)
WO (1) WO1992010202A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110651995A (zh) * 2019-10-16 2020-01-07 福建省印宝文化发展有限公司 一种野生肉灵芝浸泡工艺

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721134A (en) * 1990-12-04 1998-02-24 Il-Yang Pharmaceutical Co., Ltd. Ganoderma lucidum KCCM 10045 which produces proteoglycan (G009) having effect of antitumor immunity
RU2040932C1 (ru) * 1993-12-17 1995-08-09 Крестьянское хозяйство "Агрофирма Дижа" Препарат, влияющий на тканевой обмен и применение штамма гриба fusarium sambucinum fuckel var ossicolum (berk.et curf) bilai для его получения
US5763470A (en) * 1995-06-07 1998-06-09 Sugen Inc. Benzopyran compounds and methods for their use
US6559287B1 (en) 1998-01-24 2003-05-06 Bristol-Myers Squibb Co. Artificial proteoglycans
RU2358723C1 (ru) * 2008-01-31 2009-06-20 Андрей Александрович Иващенко Средство, обладающее антипохмельным действием, биологически активная добавка, фармацевтическая композиция, лекарственное средство и способ получения

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5452796A (en) * 1977-09-30 1979-04-25 Sato Akihiko Production of krebshemmende substance
JPS5775926A (en) * 1980-10-29 1982-05-12 Teikoku Chem Ind Corp Ltd Production of antitumor substance
EP0288959B1 (de) * 1987-04-28 1994-01-12 Meiji Milk Products Company Limited Glykoprotein, Verfahren zu dessen Herstellung und dieses als aktiven Bestandteil enthaltendes immunsuppressives Agens

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110651995A (zh) * 2019-10-16 2020-01-07 福建省印宝文化发展有限公司 一种野生肉灵芝浸泡工艺

Also Published As

Publication number Publication date
DE69133010T2 (de) 2002-12-05
EP0610499A4 (de) 1994-07-01
US5585467A (en) 1996-12-17
CA2097820A1 (en) 1992-06-05
CA2097820C (en) 2000-05-16
EP0610499A1 (de) 1994-08-17
AU8952191A (en) 1992-07-08
WO1992010202A1 (fr) 1992-06-25
AU1509097A (en) 1997-06-05
JP2583385B2 (ja) 1997-02-19
EP0610499B1 (de) 2002-05-15
KR920010763B1 (ko) 1992-12-17
KR920011511A (ko) 1992-07-24
ATE217530T1 (de) 2002-06-15

Similar Documents

Publication Publication Date Title
DK1144607T3 (da) Fremgangsmåde til præsentation af (poly)peptider/proteiner på bakteriofage partikler via disulfidbindinger
DE69723812D1 (de) Aminosäurezusammensetzungen
MX166499B (es) Interferon recombinante inmune humano y composicion farmaceutica que lo incluye
ES2092388T3 (es) Medio nutritivo para el cultivo de microorganismos.
DK289285A (da) Thymopentin analoge
HUP9901725A2 (hu) Szubtilizinváltozatok
ES2109217T3 (es) Determinante peptidico asociado con la inmunidad.
DE69133010D1 (de) Zur steigerung der antitumorimmunität wirksames proteoglykan (g009)
ES2178207T3 (es) Nuevos derivados de triptolida utiles en el tratamiento de enfermedades autoinmunes.
EP0563383A4 (en) (ganoderma lucidium) iy009 which produces proteoglycan (g009) having effect of enhancing antitumor immunity
RU93043871A (ru) Ganoderma lucidum iv.009, продуцирующий протеогликан g 009, повышающий противоопухолевый иммунитет
DE3776897D1 (de) Montagesystem fuer paneele.
MX9300759A (es) Compuestos y productos de reaccion de amadori, procedimiento para su fabricacion y su uso.
RU93043842A (ru) Протеогликан g 009 - эффективный стимулятор противоопухолевого иммунитета
KR920011512A (ko) 항종양 면역증강효과가 있는 단백다당체(s 818)
KR920012419A (ko) 항종양 면역증강효과가 있는 단백다당체(C 909)를 생성하는 코르디셉스(Cordeyceps sp.) IY909
KR920011510A (ko) 항종양 면역증강효과가 있는 단백다당체(c 909)
KR920012421A (ko) 항종양 면역증강효과가 있는 단백다당체(S 818)를 생성하는 균주 쉬조필럼 콘뮨(Schizophyllum Commune) IY 818
KR920012114A (ko) 사람 면역결핍 바이러스(HIV)의 그룹-특이 항원(gaa)의 선택된 펩타이드, 이의 제법 및 용도
DE69613086D1 (de) Antigenen Peptide mit Glycinsubstitution
PT854727E (pt) Antigenios de rejeicao tumoral apresentados pelas moleculas b44-alh e suas utilizacoes
KR890004722A (ko) 종양면역 증강 효과가 있는 단백 다당체(리오필란 a)
ES2059548T3 (es) Procedimiento de preparacion de sintones peptidicos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee